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Cylindrospermopsin (CYN) is a potent cyanotoxin recognized as an emerging human 
threat due to its cytotoxicity and potential carcinogenicity. Although the genotoxicity of CYN 
has been extensively studied in vitro, limited data are available on its in vivo genotoxicity. The 
aim of this study was to evaluate the in vivo genotoxicity of pure CYN (7.5-75 µg/kg body 
weight) after oral exposure of rats through a combined assay of the micronucleus test (MN) in 
bone marrow, and the standard and modified comet assay in stomach, liver and blood. Also, 
histopathological changes in stomach and liver were evaluated. Positive results in the MN test 
were observed in bone marrow in the exposed rats at all the tested concentrations. However, the 
comet assay revealed that CYN did not induce DNA strand breaks nor oxidative DNA damage 
in any of the tissues investigated. Finally, histopathological changes were observed in stomach 
and liver (7.5-75 µg/kg) in intoxicated rats. These results could indicate that CYN is able to 
induce irritation in stomach before its biotransformation in rats orally exposed, and genotoxicity 
in bone marrow. 
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The cyanobacterial polyketide-derived alkaloid toxin - cylindrospermopsin (CYN) - is 
one of the most active cyanotoxins which can adversely affect humans by different pathways. 
Dermal contact with CYN may occur during showering, bathing or during recreational activities 
(Pichardo et al., 2017); moreover, the main human exposure route is through ingestion of 
contaminated drinking water or dietary intake via consumption of cyanotoxins in contaminated 
food as fish, vegetables and algal dietary supplements (Testai et al., 2016). It has general 
cytotoxic activity, and in mammals can cause liver, kidney, thymus, and hearth damage 
(Pearson et al., 2010; Moreira et al., 2012). Moreover, CYN is known to induce neurotoxic 
(Hinojosa et al., 2019) and pro-genotoxic effects (Zegura et al., 2011; Puerto et al., 2018). It is 
considered a potential carcinogen (Falconer and Humpage et al., 2001). This cyanotoxin is 
gaining importance as its occurrence and expansion are increasing, in line with the CYN-
producing species. Thus, CYN is considered as an emerging toxin (Poniedzialek et al., 2012; 
Pichardo et al., 2017; Buratti et al., 2017). This cyanotoxin is produced by several 
cyanobacterial genera, such as Cylindrospermopsis, Aphanizomenon, Umezakia, Chrisosporum, 
and Anabaena, with C. raciborskii and A. ovalisporum being considered as the main CYN 
producers (Kokocinski et al., 2017). 
Cylindrospermopsin is a stable tricyclic alkaloid (415 Da) with a central functional 
guanidine moiety linked at C7 to a hydroxymethyluracil through a hydroxyl bridge (Ohtani et 
al., 1992). Some mechanisms of toxicity are linked to the presence of the uracil moiety (Banker 
et al., 2001; Shen et al., 2002). Although the genotoxicity of CYN is still controversial, the 
presence of the reactive guanidine and sulphate groups (Bain et al., 2008) suggested the possible 
interaction of CYN or its metabolites with nucleic acids. Actually, the mechanisms potentially 
involved in its genotoxicity are still under investigation (Testai et al., 2016; Hercog et al., 2017; 




Although no response on bacteria (Ames test) was detected in in vitro genotoxicity 
studies (Sieroslawaska, 2013; Puerto et al., 2018), several studies using various assays 
(reviewed by Zegura et al., 2011; Testai et al., 2016; Pichardo et al., 2017) indicated that CYN 
is pro-genotoxic and needs to be metabolically activated by cytochrome P-450 enzymes to 
become genotoxic (Bazin et al., 2010; Humpage et al., 2005; Straser et al., 2011). Straser et al. 
(2011) provided the first evidence that exposure to CYN induced transcription of CYP1A1 and 
1A2 isoforms, supporting the assumption that they are involved in CYN metabolic activation to 
electrophilic genotoxic intermediates. However, contradictory results  from studies carried out 
to elucidate if CYN is a genotoxic or a pro-genotoxic compound were reported, depending on 
the experimental model (e.g. CYN-metabolizing capabilities of the cell lines or the model  
employed), the CYN concentrations assayed, and the type of assay used. Recently, Puerto et al. 
(2018) applied a battery of different in vitro assays following the recommendations of the 
European Food Safety Authority guidelines (EFSA, 2011), this is, the bacterial reverse mutation 
test (OECD 471) and the micronucleus (MN) test (OECD 487) to investigate the genotoxicity of 
pure CYN. Negative response was reported in the Ames test, whereas positive results were 
found only when the metabolic fraction S9 was employed in the MN test, in agreement with the 
global consideration of the pro-genotoxic activity of CYN in in vitro metabolically active 
mammalian cells (Zegura et al., 2011; Puerto et al., 2018). Further in vitro test tests were carried 
out, such as the mouse lymphoma thymidine-kinase assay (OECD 490) on L5178YTk
+/-
 cells; 
and the comet assay on Caco-2 cells , including the standard and enzyme-modified versions 
(Puerto et al., 2018). Negative results were found in both assays (with and without metabolic 
activation) (Puerto et al., 218), whereas some in vitro standard comet assay studies indicated 
that CYN required metabolic activation to exhibit its genotoxic activity (Humpage et al., 2005; 
Straser et al., 2011, 2013; Zegura et al., 2011). 
Globally, the genotoxicity of CYN is still controversial, and EFSA recommended new 
studies to elucidate the mechanisms involved (Testai et al., 2016). In addition, the previous in 
vivo studies are very scarce. In mice, CYN or its metabolites were able to bind to proteins and 
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DNA forming adducts in the liver (Shaw et al., 2000; Norris et al., 2001). Increased DNA 
fragmentation was also reported in the liver of mice treated by intraperitoneal injection (i.p.) 
(Shen et al., 2002),  Bazin et al. (2012) demonstrated in mice that CYN administered either i.p. 
or orally induced primary DNA damage in the colon as well as cell death in the liver and 
kidneys. After oral dosing, it was also able to induce damage in bone marrow. However, the 
treatment doses were quite high and limited the validity of the study (Testai et al., 2016). 
Genotoxic effects were reported after the application of the comet assay and MN test on the 
liver and blood of mice treated i.p. with water contaminated with cellular content of C. 
raciborskii and with the products resulted from its chlorination (Fonseca et al., 2014). Recently, 
DNA damage in the liver of rats was reported using the alkaline comet assay after a single i.p. 
administration of C. raciborskii extract at different doses, and pure toxin (Dordevic et al., 
2017).The combination of the comet assay with bacterial repair enzymes recognizing specific 
DNA damage, such as endonuclease III (Endo III, which responds to oxidized pyrimidines), and 
formamidopyrimidine DNA glycosylase (Fpg, which recognizes altered purine bases including 
8-oxo-guanine) increases both the sensitivity of the assay in terms of the ability to detect a 
wider range of damage, and also its specificity (Azqueta et al., 2009). Despite the oxidative 
stress is  involved in the toxicity mechanisms of CYN (Guzmán-Guillén et al., 2013) it has been 
not elucidated whether this mechanism contributes to CYN genotoxicity, as negative results 
have been obtained when the enzyme-modified comet assay has been applied in vitro (Straser et 
al., 2013; Puerto et al., 2018), although this assay has not been performed in vivo to date. Thus, 
new in vivo genotoxicity studies of CYN should be performed following the recommendations 
of EFSA because of the inconclusive and contradictory results obtained previously (EFSA, 
2011; Testai et al., 2016). Furthermore, as far as we know, no in vivo studies on pure CYN 
genotoxicity were performed in rats exposed by oral route. The oral genotoxic potential of CYN 
is a topic worth of research because oral ingestion is one of the main human exposure routes to 
cyanotoxins, and the importance of genotoxicity in the risk assessment process.  
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The mechanisms of CYN genotoxicity and carcinogenicity are not totally elucidated. It 
seems that oxidative DNA damage could be involved (Sieroslawska and Rymuszka, 2015; 
Guzmán-Guillen et al., 2013a,b), although in some studies the DNA damage may not be 
induced by oxidative stress (Humpage et al., 2005; Gutiérrez-Praena et al., 2011; Straser et al., 
2013; Puerto et al., 2018). Moreover, CYN modulated the expression of some DNA damage 
response genes, such as levels of P53 regulated genes related to cell cycle arrest, DNA damage 
repair and apoptosis (Zegura et al., 2011). In vitro, at molecular level, CYN changed the 
expression of genes involved in xenobiotic metabolism, in immediate-early response/signalling, 
and DNA damage response (Hercog et al., 2017). 
Considering all these facts and following the recommendations of EFSA, the aim of the 
present work was to investigate in vivo, for the first time in rats as experimental model, the 
potential genotoxic effects induced after oral administration (gavage) of pure CYN standard, by 
application of a combined MN-comet assay. Moreover, the comet assay has been combined 
with  Endo III and Fpg enzymes. The selected target tissues were bone marrow for MN test 
(OECD 474, 2016a), and the liver, stomach (OECD 489, 2016b) and blood cells for the standard 
and enzyme-modified comet assay (endonuclease III, Endo III, E.C. 3.1.21.5 and 
formamidopyrimidine DNA glycosylase, Fpg, E.C. 3.2.2.23 ). The potential histopathological 
changes were also investigated in stomach and liver. 
 
2. Materials and methods 
2.1. Supplies and chemicals 
Cylindrospermopsin standard (purity 95%) was purchased from Alexis Corporation 
(Lausen, Switzerland). All chemicals reagents were purchased from Sigma-Aldrich (Madrid, 
Spain), C-viral S.L. (Seville, Spain), Gibco (Biomol, Seville, Spain) and Moltox (Trinova, 
Biochem, Germany). 
2.2. Animal hosting and nourishing conditions 
7 
 
The in vivo experiments were authorized by the Ethics Committee on Animal 
Experimentation of the University of Sevilla (09/03/2016/028). Moreover, all animals received 
humane care for the protection of animals utilized for scientific purposes in concordance with 
the Directive 2010/63/UE. 
Seven-week-old male Wistar rats, strain RjHan:WI (type outbred rats) were provided by 
the Centre for Animal Production and Experimentation from the University of Sevilla 
(Espartinas, Spain). After arrival, the animals were weighed and accommodated into 
polycarbonate cages with stainless steel covers. Then, the animals were acclimatised to the 
environmental conditions (12-h dark/light cycle, controlled temperature (23 ± 1 ºC), relative 
humidity (55 ± 10%) for 1 week before the experiment. During this time, the animals were fed 
with standard laboratory diet (Harlan, 2014; Harlan Laboratories, Barcelona, Spain) and water 
ad libitum.  
 
2.3. Experimental design and treatment 
The exposure dose was selected according to previous studies (Chernoff et al. 2018) in 
mice, in which slight signs of damage were observed for 75 µg CYN/kg body weight (bw) after 
90 d oral exposure; and in wistar rats, in which genotoxicity was observed for 79.80 µg CYN/kg 
body weight (bw) after i.p injection (Dordevic et al., 2017). The International Conference on 
Harmonisation (ICH) S2 guidelines and the MN and Comet assay protocols (OECD 474 and 
489, respectively) recommend the use of a maximum dose and 2 additional lower doses (Bowen 
et al., 2011) appropriately spaced by less than √10 (OECD 489, 2016b). Thus the doses were 
established at 75, 23.7 and 7.5 µg CYN/kg bw. 
Takin into account that the OECD guideline 474 (OECD, 2016a) recommends to use 5 
animals per group and the OECD 489 (OECD, 2016b), allows to use 3 animal for positive 
controls, after acclimation for 1 week, 23 male rats were weighted in order to ensure that weight 
variation did not exceed  20 % and randomly divided into 5 groups: 1 negative control group 
(C-) (5 male rats) treated with water (vehicle); 1 positive control group (C+) (3 male rats) 
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exposed to 200 mg/kg bw ethylmethanesulfonate (EMS) and 3 exposed groups (5 male rats per 
group) treated with 75; 23.7 or 7.5 µg CYN/kg bw. All doses were prepared in water in a final 
volume of 1 mL. Animals were dosed by gavage using an enteral feeding tube (Vygon, Ecouen, 
France) at 0; 24 and 45 h in agreement to the recommendations of Bowen et al. (2011). The 
animals were sacrificed 3 h after the final dose administration for combined comet and MN 
endpoints, following the recommendations of Bowen et al., (2011). During the treatment period, 
clinical signs and body weight were recorded. 
 
2.4. Sample collection 
 Selected tissues were removed, dissected, rinsed with cold saline solution and weighed. 
After weight, stomach and liver were quickly processed for the comet assay as is described in 
section 2.6. Moreover, blood samples were collected and maintained in Vacutainer
®
 sodium 
heparin tubes (Becton Dickinson, Rutherford, NJ). Samples for MN assay were collected from 
the bone marrow of both femurs of each animal and immediately processed. For the 
histopathological study, a portion of stomach and liver were collected according to Mellado-
Garcia et al., (2016) and Llana-Ruiz-Cabello et al., (2016). 
 
2.5 MN assay 
MN test was conducted following the recommendations of OECD guideline 474 
(OECD, 2016a) and Corcuera et al. (2015). Two slides, 1 per femur of each animal, were 
prepared with bone marrow cells re-suspended in a drop of foetal bovine serum. Then, these 
slides were fixed in absolute methanol, air dried and stained with 10% Giemsa. The 
polychromatic erythrocytes (PCE) among total erythrocytes (normochromatic erythrocytes 
(NCE) + (PCE)) ratio and the PCE among NCE ratio were calculated by counting 500 
erythrocytes per animal. The incidence of micronucleated immature erythrocytes (MNPCE) was 
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calculated by counting a total of 5000 PCE per animal and results were expressed as % MN, 
following Llana-Ruiz-Cabello et al., (2016). 
 
2.6. Isolation of single-cell suspensions for the comet assay 
Single cell suspensions from stomach and liver were isolated based on the methods of 
Corcuera et al. (2015) and Mellado-García et al. (2016). Briefly, tissues were washed with 
Merchant´s buffer (MB) (0.14 M NaCl, 1.47 nM KH2PO4, 2.7 mM KCl, 8.1 mM Na2HPO4, 10 
mM Na2EDTA, pH 7.4) and discarded. After that a portion of each tissue were homogenized in 
cold. Finally, the homogenates were centrifuged, filtered and mixed with 5mL buffer until slide 
preparation. Heparinized blood samples were mixed v/v (1/1) with phosphate buffered saline 
(PBS) solution and the lymphocytes were isolated with Histopaque® (Sigma-Aldrich, Madrid, 
Spain) and centrifuged (400 G, 30 min) (Llana-Ruiz-Cabello et al., 2018). Finally, the cells 




2.7. Standard and enzyme-modified comet assay 
The standard comet assay has been performed according to the recommendations of 
OECD guideline 489 (OECD, 2016b). For blood samples, 30 µL of cells suspension was mixed 
with 140 µL of 0.5% low-melting point agarose. Twelve 5 µL aliquots were placed on a 
microscope slide (Llana-Ruiz-Cabello et al., 2018). For stomach and liver, the cells suspensions 
were mixed with 1% low-melting point agarose and the mixtures were placed on a microscope 
slide similar to blood samples (Mellado-Garcia et al., 2016; Llana-Ruiz-Cabello et al., 2018). 
Then, the standard and modified comet assays were performed as previously described by 
Mellado-García et al. (2016). Briefly, after lysis, slides were washed 3 times for 5 min with 
enzyme buffer (40 mM HEPES; 0.1M KCl; 0.5 mM EDTA; 0.2 mg/mL bovine serum albumin; 
pH 8). Then, 2 gels in each slide were exposed to 30 μL lysis solution; enzyme buffer alone 
(buffer F); buffer F containing Fpg or Endo III during 30 min in a metal box at 37 ºC. 
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Afterwards, nuclei were denatured, and electrophoresis was performed for 20 min, 0.81 V/cm 
up to 400 mA. DNA was neutralized in PBS, washed with water and fixed with 70% and 
absolute ethanol before staining. Images of at least 150 randomly selected nuclei per animal 
were analysed with the image analysis software Comet Assay IV (Perceptive Instruments, UK). 
The % DNA in tail represents DNA strand breaks and oxidized damage in DNA bases. Endo III 
and Fpg sensitive sites were calculated by subtracting the % of DNA in tail after enzyme buffer 
incubation from the % of DNA in tail after repair enzymes incubation. 
 
2.8. Histopathogical analysis 
Tissue samples for histological analysis were taken from stomach and liver of control 
and exposed rats.  For light microscopy (LM), samples were fixed in 10% formaldehyde for at 
least 24 h at 4 ºC and then dehydrated in ethanol, immersed in xylol and embedded in paraffin 
wax using an automatic processor. Tissue sections of 3-5 mm were deparaffinised followed by 
rehydration, stained with haematoxylin and eosin (HE), and mounted with Crystal/Mount 
(Paraplast, Oxford Labware, St. Louis, MO). Then, liver samples were stained for glycogen 
content assessment with periodic acid Schiff (PAS) (Sigma-Aldrich, Madrid, Spain). For 
electron microscopy (EM), samples were prefixed in 2% glutaraldehyde at least for 10 h at 4 ºC. 
Then, postfixed in 1% osmium tetroxide, dehydrated in ethanol and embedded in Epon. 
Sections of 50-60 nm were cut with an LKT microtome and were mounted on a copper grid and 
stained with uranyl acetate and lead citrate. The tissue sections were examined in a Philips 
CM10 electron microscope (FEI. Eindhoven, The Netherlands). 
 
2.9. Statistical analyses 
The results of MN test are presented as mean ± SD, the analysis of variance (ANOVA) 
was performed followed by Dunnett's multiple comparison test. For the standard and enzyme 
modified comet assays, mean ± SD of the medians were calculated for each group. The 
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distribution of the data was checked for normality using the Kolmogorov-Smirnov test and total 
scores of the different groups were compared using the non-parametric Kruskal Wallis test 
followed by Dunn´s multiple comparison test. The Analyses were performed using Graph-Pad 
InStat software (Graph- PadSoftware Inc., La Jolla, USA). 
 
3. Results 
3.1 Micronucleus assay 
Significant differences in the PCE/total erythrocytes and PCE/NCE ratios were 
observed in male rats exposed to the highest concentration assayed of CYN (75 µg/kg bw; 
p<0.01), recorded 3 h after the triple dose of CYN was administrated by gavage (Table 1). The 
positive control, EMS, induced similar significant decreases. Moreover, all treated groups, at 
every tested CYN dose, exhibited significant increases in the percentage of MN in immature 
erythrocytes, when compared with the negative control group. There were no dose-dependent 
differences in any treatment. 
 
3.2 Standard and enzyme-modified comet assay 
Results in the standard comet assay showed that CYN did not induce DNA strand 
breaks in the liver, stomach or blood cells at any dose assayed (Figure 1). Moreover, no 
differences in the % of DNA in tail were observed in any tissues exposed to 7.5-75 µg/kg bw 
CYN and post-treated with Endo-III (Figure 2). In addition, the effects of CYN on liver, 
stomach and blood were analysed with Fpg post-exposure (Figure 3) and there were no 
differences observed in the frequency of Fpg-sensitive sites among samples from the exposed 
groups and negative control group in liver, stomach and blood cells.  
Positive control group exposed to EMS exhibited DNA damage in liver (p<0.001), 
stomach (p<0.001) and blood (p<0.001) cells in all the experiments (Figures 1, 2 and 3, 
respectively). 
 
3.3 Clinical and Histopathological study 
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No rats died during the experiment and no signs of toxicity were observed during the 
treatment period. In the present work, although no clinical signs of toxicity were recorded in any 
of the groups, significant altered gastric mucus secretion after oral administration of pure CYN 
was observed. Body weight changes were no observed in any treated animals. Moreover, the 
relative weight (RW) of stomachs and livers were similar in all the treated animals, and no 
significant differences were found in comparison to the negative control group (data not 
shown). Histopathological results from rats orally exposed to CYN displayed significant 
differences in stomach and liver morphology compared to the negative control group. The 
morphological study of stomachs from control and exposed rats are shown in Figure 4. In 
general, under LM and EM normal gastric mucosa was observed in the control group (Fig 4A, 
B). However, mucosal damage was observed in the CYN treated rats (Fig 4 E-J). Specifically, 
the gastric mucosa exhibited significant reactive changes in surface foveolar cells with dilated 
ducts that increased with the administered CYN concentration (Fig 4H, I). Moreover, a partial 
degranulation of surface and deep mucosa was observed in animals exposed to low doses (7.5 
and 23.7 µg/kg bw CYN) (Fig 4J, G), which was total at the highest dose (75 µg/kg bw CYN) 
and in the positive control (EMS) (Fig 4D, F). The mucous, the gastric defensive element, and 
mucous cells exhibited degenerative alterations. The mucous content of surface epithelial cells 
was decreased at 23.7 and 75 µg/kg bw CYN (Fig 4E, G). Finally, rats treated with EMS 
exhibited an increase in mucosal cells and dilation of the mucosa surface (Fig 4C). 
A normal hepatic parenchyma was observed in liver both under LM and  EM, for 
unexposed rats (Fig 5A, B). However, rats exposed to CYN exhibited significant changes. 
Firstly, some modifications in the nuclei structure were observed in treated groups. An increase 
in endomitosis with the production of binucleated hepatocytes was seen for all the doses 
assayed (Fig 5G, I, K, M, N). Moreover, animals exposed to the highest dose (75 µg/kg bw 
CYN) showed a high mitotic frequency (Fig 5I, J). These alterations were observed in the 
positive control group as well (Fig 5C, E, F). Secondly, the liver of the rats from the treated 
groups showed proliferation of smooth endoplasmic reticulum (SER) with dilation of 





The interest in the assessment of the genetic toxicity of CYN is increasing due to its 
potential carcinogenic action. Although globally this cyanotoxin is considered as pro-genotoxic, 
the in vitro toxicological assays performed until now revealed contradictory results of its 
potential genotoxicity and mechanisms of action. Furthermore, the in vivo genotoxicity studies 
are very scarce; they are carried out mainly in mice, and some are not following the 
international protocols, such as the OECD guidelines. 
It is speculated that CYN or its metabolites may exert toxic effects through DNA and/or 
RNA reactions because of its structural characteristic (its nucleoside structure and the presence 
of potentially reactive guanidine and sulphate groups) (Shen et al., 2002). Some authors 
proposed different mechanisms of action for CYN genotoxicity, such as: induction of DNA 
strand breaks (Shen et al., 2002; Humpage et al., 2005; Dordevic et al., 2017); formation of 
covalent bindings between DNA and CYN, or DNA and CYN metabolites (Shaw et al., 2000); 
and formation of micronuclei containing lagging chromosome fragments or whole 
chromosomes (Humpage et al., 2000, Sieroslawaska and Rymuszka, 2015). 
To improve in vivo genotoxicity assessment of xenobiotics in general, it is 
internationally considered that the combination/integration of the in vivo MN and Comet assay 
into a single study is scientifically justified (Rothfuss et al., 2011). In this sense, this is the first 
study which evaluated CYN in vivo genotoxic response in rats, exposed to CYN by oral route 
(gavage), combining the comet assay on cells isolated from stomach, liver and blood , and the 
MN test in bone marrow cells, following the OECD 489 and 474 guidelines (OECD, 2016b, a, 
respectively) with modifications described below. The combined assay, proposed by Bowen et 
al. (2011), has the advantage of reducing animal usage according to the 3Rs principles (Replace, 
Reduce and Refine), as it is also recommended by the OECD protocols (OECD, 2016b). 
Besides, it improves the sensitivity and specificity of the detection, and decreases the number of 
false negative results (Mughal et al., 2010; Kirkland et al., 2019). Moreover, the novelty of the 
current work is the use of DNA repair enzymes (Endo III and Fpg) which increases the 
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sensitivity of the in vivo comet assay by allowing the detection of potential oxidative DNA 
damage before the DNA break occurs (Azqueta et al., 2009; Llana-Ruiz-Cabello et al., 2016; 
Mellado-Garcia et al., 2016). 
Regarding the experimental procedure, the OECD guidelines 474 (OECD, 2016a) and 
489 (OECD, 2016b) recommends to use both sexes when relevant differences in toxicity were 
described. In this sense, although there are no studies in rats, Chernoff et al. (2018) reported that 
CYN induce more toxicity in male mice than in females. Therefore, the present study was 
carried out only in males, the more sensitive sex, in order to simplify and ensure the success of 
this complicated technique. Moreover, to determine the highest exposure dose employed in the 
present study, suitable data were studied. Although, the maximum tolerated dose (MTD), which 
is the highest dose recommended by OECD protocols has been not formerly stablished, 
previous studies regarding toxicity in rodents have been reported. In mice, Humpage and 
Falconer (2002) indicated that the no-observed-adverse-effect level (NOAEL) for CYN in mice 
was 30 µg CYN/kg bw. Some years later, Chernoff et al. (2018) tried to re-evaluate the NOAEL 
by increasing exposure concentration (75-300 µg CYN/kg bw) and reported toxicity in mice 
after 90 d oral exposure in all the concentration range assayed. In wistar rats, after i.p injection 
of 79.80 µg CYN/kg bw genotoxicity was observed (Dordevic et al., 2017). Hence, in order to 
reduce animal use, the exposure dose was selected according to these previous studies in which 
slight signs of damage were observed for 75 µg CYN/kg bw after 90 d oral exposure in mice 
(Chernoff et al. 2018), and genotoxicity in wistar rats after i.p injection of 79.80 µg CYN/kg bw 
(Dordevic et al., 2017). Once the highest dose was selected taking into account the available 
data on the scientific literature, the additional lower doses were calculated following the 
recommendations of OECD (OECD, 2016a, b). 
The significant decreases in the PCE/total and PCE/NCE ratios observed in the rats 
exposed to the highest dose of CYN is a sign of bone marrow toxicity showing the exposure of 
this tissue (e.g. evidence of the exposure of the bone marrow to a test substance may include a 
depression of the immature to mature erythrocyte ratio, PCE/NCE (OECD, 2016a)). The 
induction of MN in bone marrow cells of all CYN-exposed rats by oral route was independent 
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of treatment concentrations. In this regard, the apparent inverse dose-response observed in the 
percentage of MN, where the animals exposed to the lowest dose of CYN presented the highest 
value in percentage of MN, was not statistically significant when the data from all doses 
assayed were pooled. This positive result in MN induction is in contrast with the negative 
results reported in colonic cells of mice 24 h after an oral administration of CYN (1-4 mg/kg 
bw) and in bone marrow after i.p. administration (Bazin et al., 2012). It should be noted that 
these discrepancies in response could be explained by the differences in the experimental model 
(mice/rat); the doses applied and time of response; and general differences in the followed 
protocols. The observed in vivo induction of MN by CYN in rats confirms the in vitro genotoxic 
activity reported previously (Humpage et al., 2000, Sieroslawaska and Rymuszka, 2015). 
Previous studies reported that metabolic transformation of CYN is crucial for induction of 
toxicity and genotoxicity (Humpage et al., 2005; Fessard and Bernard, 2003; Bain et al., 2008). 
Moreover, according to Straser et al. (2011) and Hercog et al. (2017) CYN induced the up-
regulation of CYP genes CYP1A1 and CYP1A2 providing evidence that these enzymes are 
involved in the metabolic activation of the toxin. The xenobiotic-metabolising system comprises 
several hundred enzymes, which are usually expressed with high selectivity in varying tissues, 
especially in the liver of mammals. The CYP enzyme system ranks first of all the xenobiotic-
biotransforming enzymes, in catalytic versatility, involvement in the activation of CYN; and 
levels in liver endoplasmic reticulum (Parkinson et al., 2013). Therefore, it would be 
responsible of the activation of pure CYN after in vivo oral administration in rats. In this regard, 
no significant variations were found in the frequency of MN in binucleated cells (BNMN) in 
undifferentiated human hepatoma cell line HepaRG cells (Bazin et al., 2010), nor in absence of 
exogenous metabolic activation S9 fraction in L5178YTk 
+/-
 cells (Puerto et al., 2018). 
Significant increments of BNMN frequency were observed, however, in differentiated cells 
(with CYN-metabolising capability) (Bazin et a., 2010), or in the presence of S9 fraction 
(Puerto et al., 2018).  
The comet assay is an acceptable choice to confirm in vitro gene mutation activity in 
terms of general genotoxicity. It is considered an adequate assay to detect potent genotoxicants 
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in liver and gastro intestinal (GI) tract, with liver, stomach and blood being the most widely 
studied tissues (Kirkland et al., 2019). In the case of CYN, only 2 in vivo studies applied the 
alkaline comet assay in mice, reporting positive results. Thus, CYN induced DNA strand 
breakage in the liver after a single i.p. dose of 0.2 mg/kg bw (Shen et al., 2002), and in the colon 
after i.p. injection of 50-200 µg CYN/kg bw (Bazin et al., 2012). However, this administration 
is not representative of the usual oral exposure to CYN as the route of administration is one of 
the most important factors affecting the results of in vivo genotoxicity tests (Sasaki et al., 1998). 
The comet assay was also assayed in mice exposed by gavage to CYN (1-4 mg/kg bw) and 
damage was observed in colon and bone marrow samples (Bazin et al., 2012). 
In the present study, the alkaline comet assay revealed that CYN did not induce DNA 
strand breaks in any of the tested tissues (liver, stomach, and blood) at the doses and conditions 
assayed, even when histopathological changes evidenced exposure of these tissues. In contrast, 
CYN induced simple DNA breaks in the liver of mice exposed i.p. to pure CYN (Shen et al., 
2002) or to extracts of C. raciborskii (Fonseca et al., 2014) and in rats injected i.p. with CYN 
(Dordević et al., 2017).  
DNA oxidation might be a mechanism of CYN-produced genetic damage in mammals. 
This damage is mainly induced by reactive oxygen species (ROS) after toxin or xenobiotic 
exposure when elevated levels of ROS or depressed antioxidant defences may lead to an 
increase in the steady-state level of unrepaired cellular DNA damage (Azqueta et al., 2009). 
Oxidative stress is one of the toxic mechanisms proposed responsible for CYN in vitro toxicity 
(as reviewed by Pichardo et al., 2017), and in vivo in fish (Puerto et al., 2011; Guzman-Guillén 
et al., 2013a,b). Increased DNA oxidation was demonstrated in vivo in tilapia exposed to 
subchronic and low doses of CYN-producing A. ovalisporum cells (Guzmán-Guillen et al., 
2013a), with no changes induced by the pure toxin (Gutierrez-Praena et al., 2011; Guzman-
Guillen et al., 2013b, 2015). However, in the present study, the modified comet assay revealed, 
for the first time, no oxidative damage induced by CYN in pyrimidine or purine bases of the 
DNA (Endo III or Fpg, respectively) of hepatocytes, stomach and blood cells from rats exposed 
to any of the concentration assayed (7.5-75 µg CYN/kg bw). In the same way, the scarcely 
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applied in vitro enzyme-modified comet assay did not show CYN-induced oxidative DNA 
damage (Straser et al., 2013; Puerto et al., 2018).  Further in vivo studies in mammals are 
needed to elucidate the role of oxidative stress in the induced DNA damage. 
Although histopathology was generally not used to evaluate cytotoxicity in comet 
studies (Kirkland et al., 2019), the OECD recommends to evaluate histopathological changes 
associated with genotoxicity such as: cell infiltration; apoptotic or necrotic changes and 
inflammation (OECD 2016b). In the present work, although no clinical signs of toxicity were 
recorded in any of the groups, significantly altered gastric mucus secretion after oral 
administration of pure CYN was observed for the first time to our knowledge. Moreover, other 
authors reported apoptosis of lymphocytes in the Peyer´s patches in the sections of duodenum 
and jejunum of mice exposed orally to 2 and 4 mg/kg bw CYN (Bazin et al., 2012). Foveolar 
cells are mucus-producing cells which cover the inside of the stomach, protecting it from the 
gastric acid. The lesions observed in the stomach of the exposed rats could be related to a 
possibly irritant effect of the toxin because the gastric mucus is the first line of defence against 
luminal irritants (Iwabuchi et al., 2013). In fact, Seawright et al. (1999) reported that freeze-
dried cultures of C. raciborskii can induce this damage in mice exposed to 2.5 to 8.5 mg/kg bw 
of CYN equiv. These results and the absence of genotoxicity in stomach cells reinforce the 
complex metabolism of CYN, which seems to need bioactivation to exhibit genotoxic activity 
(Zegura et al., 2011; Puerto et al., 2018). 
The liver is considered the primary organ in the biotransformation of CYN (Dordevic et 
al., 2017), and CYP450-derived metabolites of this toxin were responsible for both the acute 
cytotoxicity and genotoxicity (by comet assay) observed in vivo in mice (Humpage et al., 2005). 
Following this hypothesis, some differences in toxicity should be observed towards other organs 
where biotransformation has not yet occurred (such as the stomach) by the time CYN reaches 
the liver. In the present work, some histopathological changes observed in the liver cells of 
intoxicated rats could be related with its genotoxicity and with tumour development. In this 
regard, the changes observed in the liver cytoplasmic organoids of rats exposed to CYN (such 
as proliferation of RER and SER, or vacuolization) are in agreement with previous results 
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reported for rats exposed i.p. to CYN (Dordević et al., 2017), and to C. raciborskii extracts i.p 
or by gavage (Falconer et al., 1999). In general, the liver changes in the present work are 
smaller than those reported previously in mice exposed to C. raciborskii extracts (Hawkins et 
al., 1985) or in fish exposed to a single dose of CYN by gavage (200 or 400 µg CYN/kg bw) 
(Puerto et al., 2014). Humpage and Falconer (2002) showed that hepatocyte injury was more 
evident in mice exposed orally to CYN concentrations above 120 µg/kg bw/day, with an 
increase in the presence of massive necrosis or inflammation processes. Hence, some authors 
reported no histopathological damage after an exposure of up to 3 µg/kg bw CYN in rats 
(Almeida et al., 2013). In general, the histopathological changes reported in this study could be 
related with degradation processes induced by xenobiotics (Agellon and Michalak, 2017). The 
dilation observed in SER could indicate toxicity induced in the smooth surface elements, 
vulnerable to hepatotoxic agents (Richard and Stenger, 1970), like CYN, whose hepatotoxicity 
was previously demonstrated in several in vivo models, in mammals (Seawright et al., 1999; 
Falconer et al., 1999, 2001; Humpage and Falconer, 2003; Bazin et al., 2012; Dordevic et al., 
2017) and in fish (Gutierrez-Praena et al., 2012; Puerto et al., 2014). In the present work, 
degenerative changes were observed at perilobular hepatocytes in rats exposed to low doses of 
CYN (7.5 or 23.7 µg/kg bw), while the highest dose (75 µg/kg bw) induced changes in both 
perilobular and centrillobular hepatocytes. In some cases, the severity of the lesions increases 
with the dose. Necrosis or apoptosis of hepatocytes of mice were reported after oral (2.5-8.3 mg 
CYN equivalents/kg bw) (Seawright et al., 1999), intraperitoneal (50 µg/kg bw CYN) (Chernoff 
et al., 2010), or oral subchronic exposure to CYN (Chernoff et al., 2018). Moreover, the 
presence of polyploid cells observed at all doses of CYN could be associated with abnormal cell 
division because of cellular stress (toxic exposure) or with tumour development (Gentric and 
Desdouets, 2014). High mitotic frequency was observed in animals exposed to the highest dose 
(75 µg/kg bw CYN). The proliferation of hepatocytes as a manifestation of toxicity may occur 




The present results add significantly to the current state of knowledge on the genotoxic 
effects of CYN. The number of in vivo studies on the topic remains, however, limited and 
further research is needed to confirm these findings and elucidate the role of oxidative stress in 
the induced DNA damage.  
 
5. Conclusions 
We can conclude that at the concentrations assayed CYN is able to induce genotoxicity 
in bone marrow, but not in liver, stomach and blood samples of wistar rats orally exposed in a 
combined MN-Comet assay applying OECD protocols. Moreover, the histopathological 
changes in stomach and liver suggest that metabolic transformation of CYN is needed to induce 
toxicity and genotoxicity. Therefore, further research is necessary to elucidate the toxicological 
profile and mechanisms of action of CYN as the number of in vivo studies on CYN genotoxicity 
evaluated by oral exposure are scarce. 
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Figure 1: The level of DNA damage measured in stomach, liver and blood of male rats 
exposed to CYN as the formation of strand breaks (SBs) by the standard comet assay. The 
levels of DNA strand breaks are expressed as % DNA in tail. All values are expressed as mean 
± SE. ***(P<0.001) Significantly different from control. 
Figure 2: The level of DNA damage measured in stomach, liver and blood of male rats 
exposed to CYN as the formation of oxidative DNA damage as Endo III-sensitive sites. The 
levels of oxidised pyrimidines are expressed as % DNA in tail. All values are expressed as mean 
± SE. *** (P<0.001) Significantly different from control. 
Figure 3: The level of DNA damage measured in stomach, liver and blood of male rats 
exposed to CYN as the formation of oxidative DNA damage as Fpg-sensitive sites. The levels 
of oxidised purines are expressed as % DNA in tail. All values are expressed as mean ± SE. 
***(P<0.001) Significantly different from control. 
Figure 4. Histopathological changes in stomach of rats treated with CYN. (A, C, E, G, I) 
HE stained stomach section. Bars, 100 µm. (B, D, F, H, J) Ultrastructural observations. Bars, 5, 
10, 2, 2, 5 µm, respectively. (A, B) Negative control rats. (A) Details of gastric mucosa with 
normal gastric cells. (B) Details of normal mucosa cell. (C, D) Positive control rats exposed to 
EMS. (C) Details of the increase of mucosa cells (circle) and dilation of secretory ducts 
(arrows). (D) Mucosa cells degranulation (circle). (E, F) Rats treated with 75 µg/kg bw CYN. 
(E) Details of gastric mucosa with a decrease in mucous cells (circle). (F) Hyalinization of 
mucous cells (circle). (G, H) Rats treated with 23.7 µg/kg bw CYN. (G) Degenerative changes 
in the superficial mucosa. (H) Dilation of intracellular canaliculi of gastric parietal cells (circle). 
(I, J) Rats treated with 7.5 µg/kg bw CYN. (I) Excretory ducts dilated and full of mucosal 
substance. (J) Mucosa cells degranulation (circle). 
Figure 5. Histopathological changes in liver of rats treated with CYN. (A, C, E, G, I, K, 
M) HE stained stomach section. Bars, 50, 50, 50, 100, 100, 100, 100 µm, respectively. (B, D, F, 
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H, J, L, N) Ultrastructural observations. Bars, 2, 3, 3, 5, 2, 2, 10 µm, respectively. (A, B) 
Negative control rats. (A) Normal hepatic parenchyma. (B) Details of apparently normal 
hepatocytes. (C, D, E, F) Positive control rats exposed to EMS. (C) Details of hepatic cordons 
with binucleated hepatocytes (circle). (D) Details of dilated rough endoplasmic reticulum (RER) 
and smooth endoplasmic reticulum (SER). (E) Details of polyploids hepatocytes and mitosis 
(arrow). (F) Details of chromosomes from mitosis (arrow). (G, H, I, J) Rats treated with 75 
µg/kg bw CYN. (G) Details of liver parenchyma with polyploids (arrow) and binucleated 
(circle) hepatocytes. (H) Details of dilated smooth endoplasmic reticulum (circle). (I) Details of 
liver parenchyma with polyploids and binucleated hepatocytes in mitosis (circle). (J) Details of 
chromosomes from mitosis (arrow). (K, L) Rats treated with 23.7 µg/kg bw CYN. (K) Details of 
liver parenchyma with polyploids (arrow) and binucleated (circle) hepatocytes. (L) Details of 
perilobular hepatocytes with dilated smooth endoplasmic reticulum (circle). (M, N) Rats treated 
with 7.5 µg/kg bw CYN. (M) Details of liver parenchyma with polyploids (arrow) and 








Table 1: Micronucleus assay results.  Bone marrow cytotoxicity expressed as 
polychromatic erythrocytes (PCE) among total erythrocytes (normochromatic erythrocytes 
(NCE) + PCE), ratio PCE among NCE and the micronuclei induction expressed as % MN. All 
values are expressed as mean ± SD. The significant levels observed are *p<0.05, ** p<0.01, or 
***p<0.001. 
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